[Organization and management of acute complete atrioventricular block: Results from a Multicenter National Survey]

Ann Cardiol Angeiol (Paris). 2021 Apr;70(2):68-74. doi: 10.1016/j.ancard.2021.01.007. Epub 2021 Feb 26.
[Article in French]

Abstract

Background: Complete atrioventricular block (AVB3) may be an urgent potentially lifethreatening situation. Our objective was to describe the routine management of AVB 3, with emphasis on the organizational aspects.

Methods: From September 2019 to November 2019, a prospective national survey including 28 questions was electronically sent to 100 physicians (Google Form).

Results: The answers were collected from 93 physicians (response rate 93%). Permanent pacemaker implantation during weekends and nights (after 8PM) is possible for 49% of the operators (<5 times a year), for 15% (>5 times a year), impossible for 36% of the operators. For AVB3 nonresponsive to isoproterenol occurring during the night, a temporary pacing lead (TPL) is implanted by: the on-site medical staff on-duty (27%), the on-call interventional cardiologist (21%), the on-call electrophysiologist (19%), a permanent pacemaker is implanted by the electrophysiologist (12%), the strategy is not standardized (15%). An externalized active fixation lead (AFL) for AVB3 has already been implanted by 50% of the operators. 80 (86%) have already observed a dislocation of the TPL, a cardiac perforation already occurred in 57 (61%), a groin hematoma in 35 (38%), and this technique was proscribed for 4% of the operators.

Conclusion: Our survey shows important disparities in terms of management of AVB3 among the different centers. An externalized AFL with a reusable generator was used by half of the centers.

Keywords: Active fixation lead; Bloc atrioventriculaire complet; Complete atrioventricular block; Sonde de stimulation à fixation active; Sonde de stimulation électro-systolique; Stimulation temporaire; Temporary pacing lead.

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • After-Hours Care / organization & administration*
  • After-Hours Care / statistics & numerical data
  • Aged
  • Algeria
  • Atrioventricular Block / therapy*
  • Cardiotonic Agents / therapeutic use
  • Drug Resistance
  • France
  • Health Care Surveys*
  • Heart Injuries / epidemiology
  • Hematoma / epidemiology
  • Humans
  • Isoproterenol / therapeutic use
  • Mali
  • Middle Aged
  • Monaco
  • Morocco
  • Pacemaker, Artificial* / adverse effects
  • Prospective Studies
  • Prosthesis Implantation / adverse effects
  • Prosthesis Implantation / methods
  • Tunisia

Substances

  • Cardiotonic Agents
  • Isoproterenol